Bulevirtide Linked to Less Decompensation in Chronic Hep D With Cirrhosis
(MedPage Today) -- In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with lower risk of liver decompensation, according to results from a European retrospective study. Among more...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.